Cocrystal Pharma Inc Stock OTC Bulletin Board
Equities
US19188J1025
Pharmaceuticals
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 15.36M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -24M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.66
x | P/E ratio 2025 * |
-0.77
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.97% |
Managers | Title | Age | Since |
---|---|---|---|
Sam Lee
CEO | Chief Executive Officer | 64 | 14-01-01 |
James Martin
CEO | Chief Executive Officer | 58 | 17-02-22 |
Roger Kornberg
CHM | Chairman | 77 | 14-01-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
BRD | Director/Board Member | 87 | 14-01-01 |
Director/Board Member | 68 | 21-05-26 | |
Steven Rubin
BRD | Director/Board Member | 63 | 14-01-01 |
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.78B | |
+20.44% | 21.89B | |
+10.86% | 14.45B | |
+13.07% | 13.63B | |
+37.46% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.06B |